查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1233129

2023-2030 年按技術（NGS、其他）按工作流程按應用按類型按最終用途按地區按細分趨勢分列的靶向測序和重測序市場規模、份額和趨勢分析報告

Targeted Sequencing And Resequencing Market Size, Share & Trends Analysis Report By Technology (NGS, Others), By Workflow, By Application, By Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

靶向測序和重測序市場增長和趨勢

Grand View Research, Inc. 的新報告顯示，全球靶向測序和重測序市場規模從 2023 年到 2030 年將以 22.59% 的複合年增長率增長，預計將達到 257 億美元

基因組測序儀的持續技術發展以及 NGS 技術的廣泛應用和採用預計將推動市場增長。 此外，預計 NGS 在分子診斷和精準醫學中的應用擴大也將為市場增長創造機會。

NGS 連同無創產前檢測、移植醫學和藥物基因組學，預計將越來越多地被用於治療各種疾病和傳染病。 靶向基因組和通過 qPCR 進行的基因表達譜分析是 NGS 測序在病理實驗室中最常見的兩個應用。 雖然腫瘤學仍然是臨床使用 NGS 的主要領域，但病理學家有望在未來幾年在其他領域採用 NGS。 預計這些因素將在預測期內推動市場增長。

另一方面，新產品的推出有望推動靶向測序和重測序市場的增長。 例如，2022 年 10 月，Illumina 基因組學論壇宣布推出 NovaSeq X，該系統每年能夠在一個系統中運行大約 20,000 個全基因組。 這個新系統有 100 億個流通池。 使用 2x150 鹼基對讀取時輸出 6TB。 此外，2021 年 12 月，F. Hoffmann-La Roche AG 宣布推出 AVENIO Edge System，以簡化 NGS 樣品製備的自動化並推進精準醫學。 這個新穎的系統是一個端到端的集成預分析平台，可提供始終如一的高質量結果。

靶向測序和重測序市場的主要參與者正在專注於合作以鞏固其市場地位。 例如，2021 年 3 月，Illumina 與 Genseeq 合作，在中國商業化和開髮用於癌症治療的 IVD NGS 試劑盒。 該新型試劑盒是使用 Illumina 的 NextSeq 550Dx 測序系統開發的，並已獲得中國 NMPA（國家藥品監督管理局）的批准。 此外，2021 年 3 月，Hackensack Meridian Health 和基因組檢測合作社 (GTC) 建立了合作夥伴關係，在美國建立了一個腫瘤學特異性 RNA 和 DNA 測序實驗室。 該實驗室（Anthology Diagnostics）將對液體活檢樣本中的游離 DNA 和腫瘤樣本中的 DNA/RNA 進行 NGS。

靶向測序和重測序市場報告亮點

  • 整體靶向測序和重測序市場的增長歸功於 NGS 在疾病診斷、藥物開發和研究應用等各種應用中的日益普及。
  • 在測序技術方□□面，由於基因組測序在人類基因研究、微生物研究、癌症研究等領域的應用越來越廣泛，因此測序領域在市場上佔據主導地位。
  • 2022年，臨床應用領域將佔據很大份額。 靶向測序廣泛應用於患者分層和靶向治療藥物開發的臨床研究和試驗中。
  • 藥物開發領域預計在未來幾年會佔據很大的市場份額。 NGS 技術可以開發藥物開發過程所需的多個級別的基因組數據，從基因改變到轉錄組量化和分析再到表觀遺傳修飾。
  • 在最終用途方面，預計醫院和診所在預測期內將佔據很大的市場份額。 這是由於臨床醫生越來越多地使用 NGS 來測試多個基因的突變、拷貝數改變和融合。
  • 北美在 2022 年主導了靶向測序和重測序市場，這歸功於主要參與者的存在以及政府為增加 NGS 技術的採用而做出的有利努力。

內容

第一章調查方法及範圍

  • 信息採購
  • 信息或數據分析
  • 市場範圍和細分定義
  • 市場模型
    • 市場調查，按公司市場份額
    • 區域分析

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第 3 章市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場系列展望
    • 母公司市場展望
    • 相關/子公司市場前景
  • 市場趨勢和前景
  • 市場動態
    • 與採用靶向測序方法和降低測序成本相關的成本降低優勢
    • 與靶向基因組合和擴增子測序相關的優勢
    • 測序技術和相關輔助協議方面的技術進步
    • 在更短的時間內完成測序的進步
    • 數字化二代測序技術簡介
    • 基於靶向測序的研究項目有所增加，隨之而來的是基因組醫學的普及
  • 市場製約因素分析
    • 新興國家在處理和管理測序技術方□□面面臨的挑戰
    • 與設置和維護測序設施相關的高成本
    • 缺乏熟練和訓練有素的人員
    • 使用基因組數據操作和分析工具的機會有限
  • 2022 年滲透率和增長前景圖
  • 商業環境分析
    • SWOT 分析；按因素（政治和法律、經濟和技術）
    • 波特的五力分析
  • COVID-19 影響分析

第 4 章技術業務分析

  • 靶向測序和重測序市場：技術波動分析
  • 測序
  • 重新排序
      • 基於電泳的測序
      • 下一代測序
      • 基於陣列的測序

第五章應用業務分析

  • 靶向測序和重測序市場：應用差異分析
  • 臨床應用
  • 動植物科學
  • 藥物開發

第6章類型業務分析

  • 靶向測序和重測序市場：類型變異分析
  • 基於 DNA 的靶向測序
  • 基於 RNA 的靶向測序

第 7 章最終用途業務分析

  • 靶向測序和再測序市場：最終用途變異分析
  • 醫院和診所
  • 學術研究
  • 其他

第八章區域業務分析

  • 2022 年和 2030 年各地區的靶向測序和重測序市場份額
  • 北美
    • SWOT 分析
    • 美國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 加拿大
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 歐洲
    • SWOT 分析
    • 德國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 英國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 法國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 意大利
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 西班牙
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 丹麥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 瑞典
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 挪威
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 亞太地區
    • SWOT 分析
    • 日本
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 中國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 印度
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 韓國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 澳大利亞
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 泰國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 拉丁美洲
    • SWOT 分析
    • 巴西
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 墨西哥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 阿根廷
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 多邊環境協定
    • SWOT 分析
    • 南非
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 沙特阿拉伯
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 科威特
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景

第9章競爭格局

  • Participant's overview
  • Financial performance
  • Participant categorization
    • 市場領導者
    • 2022 年靶向測序和重測序市場份額分析
    • 公司簡介
      • Illumina, Inc.
      • F. Hoffmann-La Roche Ltd
      • Agilent Technologies
      • GATC Biotech Ag
      • Oxford Nanopore Technologies
      • Thermo Fisher Scientific, Inc.
      • DNASTAR Inc.
      • QIAGEN
      • BGI
      • Perkin Elmer, Inc.
      • PacBio
      • Bio-Rad Laboratories, Inc.
      • Integrated DNA Technologies, Inc.
      • RainDance Technologies, Inc.
      • PierianDx
      • Genomatix GmbH
      • Macrogen, Inc.
    • 戰略規劃
      • 分機
      • 得到
      • 協作
      • 推出產品/服務
      • 夥伴關係
      • 其他
Product Code: GVR-4-68040-031-6

Targeted Sequencing And Resequencing Market Growth & Trends:

The global targeted sequencing and resequencing market size is expected to reach USD 25.7 billion expanding at a CAGR of 22.59% from 2023 to 2030, according to a new report by Grand View Research, Inc. Owing to the continuous technological developments in genome sequencers along with broad applications and adoption of NGS technology is expected drive the market growth. Furthermore, the increasing application of NGS in molecular diagnostics and precision medicione is also anticipated to create growth opportunities for market growth.

NGS is expected to witness increasing adoption in various disease conditions and infectious disease treatment, along with Noninvasive Prenatal Testing, transplant medicine, and pharmacogenomics. Targeted gene panels and gene expression profiling through qPCR remain the two most common applications for NGS sequencers in a pathology laboratory. While oncology remains a primary area of NGS use in clinics, pathologists are expected to adopt it in other areas too over the coming years. Such factors are expected to boost market growth in the forecast period.

On the other hand, the introduction of novel products is expected to boost targeted sequencing and resequencing market growth. For instance, in October 2022, the Illumina genomics Forum introduced the NovaSeq X, which can run around 20,000 whole genomes a year on one system. This novel system has 10 billion flow cells. When run at 2×150 base pair reads, it will output 6 TB. Moreover, in December 2021, F. Hoffmann-La Roche AG launched the AVENIO Edge System for simplifying the automation of NGS sample preparation and driving advancements in precision medicine. This novel system is a pre-analytical platform that offers end-to-end, integrated, consistently high-quality outcomes.

Key entities in the targeted sequencing & resequencing market are focusing on collaboration to strengthen their market position. For instance, in March 2021, Illumina collaborated with Geneseeq to commercialize and develop IVD NGS kits in China for cancer care. This novel kit was developed by using Illumina's NextSeq 550Dx sequencing system, which was approved by China's NMPA (National Medical Products Administration). Moreover, in March 2021, Hackensack Meridian Health and Genomic Testing Cooperative (GTC) entered into a partnership to establish an oncology-focused RNA and DNA sequencing laboratory in the U.S. This lab-Anthology Diagnostics-will perform NGS of cell-free DNA from liquid biopsy samples and DNA/RNA from tumor samples.

Targeted Sequencing And Resequencing Market Report Highlights:

  • The growth of the overall targeted sequencing and resequencing market is attributed to the increase in the adoption of NGS for various applications including disease diagnosis, drug development, and research applications
  • By sequencing technology, sequencing segment dominated the market owing to the increase in applications of genome sequencing in human genetic research, microbial research, cancer research, and others
  • Clinical application segment held a major share in 2022. Targeted sequencing has broadly applied in clinical research and trials for patient categorization and the development of targeted therapeutics
  • Drug development segment is expected to show significant market share in the coming years. NGS technology can develop multiple levels of genomic data needed for the drug development process from genetic modification, to transcriptome quantification and profiling, and epigenetic modifications, among others
  • By end-use, Hospitals and clinics is expected show a significant market share in the forecast period. This is attributed to the increasing usage of NGS bu clinicians to test several genes for mutations, copy number changes, and fusions
  • North America dominated the targeted sequencing and resequencing market in 2022 due to the presence of key players and favorable government initiatives from the government for increased adoption of NGS technologies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Cost-saving advantages pertaining to the adoption of targeted sequencing approach as well as reducing sequencing cost
    • 3.4.2. Advantages associated with targeted gene panels and amplicon sequencing
    • 3.4.3. Technological advancements in sequencing technology and related ancillary protocols
    • 3.4.4. Advancements to perform sequencing in less time
    • 3.4.5. Introduction of digital next-generation sequencing technology
    • 3.4.6. Rising number of targeted sequencing-based research projects and consequent popularity growth of genomic medicine
  • 3.5. Market Restraint Analysis
    • 3.5.1. Challenges in handling & managing sequencing technologies in developing countries
    • 3.5.2. High cost associated with installation & maintenance of sequencing facility
    • 3.5.3. Lack of skilled & trained personnel
    • 3.5.4. Limited access to tools for genomic data manipulation and analysis
  • 3.6. Penetration and Growth Prospect Mapping 2022
  • 3.7. Business Environment Analysis
    • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.7.2. Porter's Five Forces Analysis
  • 3.8. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Targeted Sequencing and Resequencing Market: Technology Movement Analysis
  • 4.2. Sequencing
    • 4.2.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 4.3. Re sequencing
    • 4.3.1. Re sequencing market, 2018 - 2030 (USD Million)
      • 4.3.1.1. Electrophoresis-based sequencing
      • 4.3.1.1.1. Electrophoresis-based sequencing market, 2018 - 2030 (USD Million)
      • 4.3.1.2. NGS
      • 4.3.1.2.1. NGS market, 2018 - 2030 (USD Million)
      • 4.3.1.3. Array-based sequencing
      • 4.3.1.3.1. Array-based sequencing market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Targeted Sequencing and Resequencing Market: Application Movement Analysis
  • 5.2. Clinical applications
    • 5.2.1. Clinical applications market, 2018 - 2030 (USD Million)
  • 5.3. Plant and animal sciences
    • 5.3.1. Plant and animal sciences market, 2018 - 2030 (USD Million)
  • 5.4. Drug development
    • 5.4.1. Drug development market, 2018 - 2030 (USD Million)

Chapter 6. Type Business Analysis

  • 6.1. Targeted Sequencing and Resequencing Market: Type Movement Analysis
  • 6.2. DNA-based targeted sequencing
    • 6.2.1. DNA-based targeted sequencing market, 2018 - 2030 (USD Million)
  • 6.3. RNA-based targeted sequencing
    • 6.3.1. RNA-based targeted sequencing market, 2018 - 2030 (USD Million)

Chapter 7. End-use Business Analysis

  • 7.1. Targeted Sequencing and Resequencing Market: End-use Movement Analysis
  • 7.2. Hospitals and clinics
    • 7.2.1. Hospitals and clinics market, 2018 - 2030 (USD Million)
  • 7.3. Academic research
    • 7.3.1. Academic research market, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Targeted Sequencing and Resequencing Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. U.S. Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD MILLION)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Canada Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. Germany Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.4. U.K.
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. UK Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. France Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Italy Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Spain Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Denmark Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Sweden Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Target Disease Prevalence
      • 8.3.10.3. Competitive Scenario
      • 8.3.10.4. Regulatory Framework
      • 8.3.10.5. Reimbursement Scenario
      • 8.3.10.6. Norway Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
      • 8.4.1.1. Asia Pacific Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Reimbursement Scenario
      • 8.4.2.6. Japan Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. China Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. India Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. South Korea Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. Australia Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Reimbursement Scenario
      • 8.4.7.6. Thailand Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Brazil Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Reimbursement Scenario
      • 8.5.4.6. Mexico Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.5.5. Argentina
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. Reimbursement Scenario
      • 8.5.5.6. Argentina Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. South Africa Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. Saudi Arabia Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. UAE Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Regulatory Framework
      • 8.6.6.5. Reimbursement Scenario
      • 8.6.6.6. Kuwait Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant's overview
  • 9.2. Financial performance
  • 9.3. Participant categorization
    • 9.3.1. Market Leaders
    • 9.3.2. Targeted Sequencing and Resequencing Market Share Analysis, 2022
    • 9.3.3. Company Profiles
      • 9.3.3.1. Illumina, Inc.
      • 9.3.3.2. F. Hoffmann-La Roche Ltd
      • 9.3.3.3. Agilent Technologies
      • 9.3.3.4. GATC Biotech Ag
      • 9.3.3.5. Oxford Nanopore Technologies
      • 9.3.3.6. Thermo Fisher Scientific, Inc.
      • 9.3.3.7. DNASTAR Inc.
      • 9.3.3.8. QIAGEN
      • 9.3.3.9. BGI
      • 9.3.3.10. Perkin Elmer, Inc.
      • 9.3.3.11. PacBio
      • 9.3.3.12. Bio-Rad Laboratories, Inc.
      • 9.3.3.13. Integrated DNA Technologies, Inc.
      • 9.3.3.14. RainDance Technologies, Inc.
      • 9.3.3.15. PierianDx
      • 9.3.3.16. Genomatix GmbH
      • 9.3.3.17. Macrogen, Inc.
    • 9.3.4. Strategy Mapping
      • 9.3.4.1. Expansion
      • 9.3.4.2. Acquisition
      • 9.3.4.3. Collaborations
      • 9.3.4.4. Product/Service Launch
      • 9.3.4.5. Partnerships
      • 9.3.4.6. Others

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 7 Global Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 Global Targeted sequencing and resequencing market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America Targeted sequencing and resequencing market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 North America Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 13 North America Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 15 U.S. Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 17 U.S. Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Canada Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Canada Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 20 Canada Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 21 Canada Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Europe Targeted sequencing and resequencing market, by Country, 2018 - 2030 (USD Million)
  • Table 23 Europe Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Europe Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 25 Europe Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 26 Europe Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Germany Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Germany Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 30 Germany Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 U.K. Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 32 U.K. Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 33 U.K. Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 34 U.K. Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 France Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 36 France Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 37 France Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 38 France Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Italy Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Italy Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 41 Italy Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 42 Italy Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Spain Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Spain Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 45 Spain Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 46 Spain Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Denmark Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Denmark Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 49 Denmark Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 50 Denmark Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Sweden Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Sweden Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 53 Sweden Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 54 Sweden Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Norway Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Norway Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 57 Norway Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 58 Norway Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Targeted sequencing and resequencing market, by Country, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 China Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 65 China Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 66 China Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 67 China Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Japan Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Japan Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 70 Japan Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 71 Japan Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 India Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 73 India Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 74 India Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 75 India Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Australia Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Australia Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 78 Australia Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 79 Australia Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 South Korea Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Korea Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 82 South Korea Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 83 South Korea Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 Thailand Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 85 Thailand Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 86 Thailand Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 87 Thailand Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Latin America Targeted sequencing and resequencing market, by Country, 2018 - 2030 (USD Million)
  • Table 89 Latin America Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Latin America Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 91 Latin America Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 92 Latin America Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 93 Brazil Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 94 Brazil Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 95 Brazil Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 96 Brazil Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 97 Mexico Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 98 Mexico Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 99 Mexico Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 100 Mexico Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 101 Argentina Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 102 Argentina Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 103 Argentina Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 104 Argentina Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Targeted sequencing and resequencing market, by Country, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 109 Middle East & Africa Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 110 South Africa Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 111 South Africa Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 112 South Africa Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 113 South Africa Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 117 Saudi Arabia Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 118 UAE Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 119 UAE Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 120 UAE Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 121 UAE Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 125 Kuwait Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Targeted Sequencing And Resequencing, Market Segmentation
  • Fig. 8 Market Snapshot, 2021
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 16 Global Targeted Sequencing And Resequencing Market: Technology Movement Analysis
  • Fig. 17 Global Targeted Sequencing And Resequencing Market, for Sequencing, 2018 - 2030 (USD Million)
  • Fig. 18 Global Targeted Sequencing And Resequencing Market, for Re sequencing, 2018 - 2030 (USD Million)
  • Fig. 19 Targeted Sequencing And Resequencing Market, for Electrophoresis-based resequencing, 2018 - 2030 (USD Million)
  • Fig. 20 Targeted Sequencing And Resequencing Market, for NGS, 2018 - 2030 (USD Million)
  • Fig. 21 Targeted Sequencing And Resequencing Market, for Array-based resequencing, 2018 - 2030 (USD Million)
  • Fig. 22 Global Targeted Sequencing And Resequencing Market, for Application, Movement Analysis
  • Fig. 23 Global Targeted Sequencing And Resequencing Market, for Clinical application, 2018 - 2030 (USD Million)
  • Fig. 24 Global Targeted Sequencing And Resequencing Market, for Plant and animal sciences,2018 - 2030 (USD Million)
  • Fig. 25 Global Targeted Sequencing And Resequencing Market, for Drug development, 2018 - 2030 (USD Million)
  • Fig. 26 Global Targeted Sequencing And Resequencing Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Global Targeted Sequencing And Resequencing Market, for type, Movement Analysis
  • Fig. 28 Global Targeted Sequencing And Resequencing Market, for DNA-based targeted sequencing, 2018 - 2030 (USD Million)
  • Fig. 29 Global Targeted Sequencing And Resequencing Market, for RNA-based targeted sequencing, 2018 - 2030 (USD Million)
  • Fig. 30 Global Targeted Sequencing And Resequencing Market, for End-use, Movement Analysis
  • Fig. 31 Global Targeted Sequencing And Resequencing Market, for Hospitals & clinics, 2018 - 2030 (USD Million)
  • Fig. 32 Global Targeted Sequencing And Resequencing Market, for Academic research, 2018 - 2030 (USD Million)
  • Fig. 33 Global Targeted Sequencing And Resequencing Market, for Others,2018 - 2030 (USD Million)
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 Regional Outlook, 2022 & 2030
  • Fig. 36 Global Targeted Sequencing And Resequencing Market: Region Movement Analysis
  • Fig. 37 North America Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 42 U.K. Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Targeted Sequencing And Resequencing Market,2018 - 2030 (USD Million)
  • Fig. 47 Denmark Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 51 China Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 52 India Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait Targeted Sequencing And Resequencing Market, Ansoff Matrix
  • Fig. 64 Market differentiators
  • Fig. 65 Key company market share analysis, 2022
  • Fig. 66 Company market position analysis
  • Fig. 67 Competitive dashboard analysis
  • Fig. 68 Regional network map